Related Experiment Video
Updated: Jul 14, 2026

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors
Published on: July 28, 2023
[Targeting allotopic material to the mitochondrial compartment: new tools for better understanding mitochondrial
Pierre Rustin1, Howard T Jacobs, André Dietrich
1Inserm U676, Hôpital Robert Debré et Université Paris 7, Faculté de Médecine Denis Diderot, Paris, France. Pierre.Rustin@rdebre.inserm.fr
Abstract:
Mitochondrial disorders can not be ignored anymore in most medical areas. They include specific and widespread organ involvement, with tissue degeneration or tumor formation, being the target of numerous viruses, e.g. the HIV. Primary or secondary actors, mitochondrial dysfunctions are also supposedly playing a role in the ageing process. Despite the progresses made in the identification of their molecular bases, nearly all remains to be done as regards therapy. Research dealing with mitochondrial physiology and pathology has a long history in France and is thus not a surprise if four French teams, coming from these fundamental domains, are involved in the challenge to find ways to fight these diseases. The directions described are working tracks which promise to be long and full of pitfalls. Being original, they share a part of risk and uncertainty, but they are also with great potential with high stakes if considering the impact of these diseases.
Insights
Mitochondrial disorders impact multiple organs and aging. Current therapies are limited, but new research in France offers potential for novel treatments for these complex diseases.
Area of Science:
- Biomedical Science
- Pathology
- Virology
Context:
- Mitochondrial disorders present significant clinical challenges across various medical fields.
- These conditions involve organ damage, tissue degeneration, tumor formation, and are implicated in viral infections like HIV and the aging process.
- Despite advances in understanding molecular causes, effective therapeutic strategies remain largely undeveloped.
Purpose:
- To explore novel therapeutic avenues for mitochondrial disorders.
- To leverage France's strong research history in mitochondrial physiology and pathology.
- To address the unmet need for treatments targeting mitochondrial dysfunction.
Summary:
- Four French research teams are investigating innovative approaches to combat mitochondrial disorders.
- Research directions are original, potentially risky, but hold significant promise for treating diseases linked to mitochondrial dysfunction.
- The focus is on fundamental research with the potential for high therapeutic impact.
Impact:
- Advances in treating mitochondrial disorders could improve patient outcomes and quality of life.
- Understanding mitochondrial roles in aging and disease may lead to broader health interventions.
- This research has the potential to significantly impact public health by addressing debilitating conditions.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

